Differences in incidence and trends of haematological malignancies in J apan and the U nited S tates D Chihara, H Ito, T Matsuda, A Shibata, A Katsumi, S Nakamura, ... British journal of haematology 164 (4), 536-545, 2014 | 330 | 2014 |
Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes CY Cheah, D Chihara, JE Romaguera, NH Fowler, JF Seymour, ... Annals of Oncology 26 (6), 1175-1179, 2015 | 177 | 2015 |
Long‐term survival and conditional survival of cancer patients in Japan using population‐based cancer registry data Y Ito, I Miyashiro, H Ito, S Hosono, D Chihara, K Nakata‐Yamada, ... Cancer science 105 (11), 1480-1486, 2014 | 166 | 2014 |
Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan T Tokunaga, K Shimada, K Yamamoto, D Chihara, T Ichihashi, R Oshima, ... Blood, The Journal of the American Society of Hematology 119 (12), 2837-2843, 2012 | 140 | 2012 |
Malignancy‐associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes GN Tamamyan, HM Kantarjian, J Ning, P Jain, K Sasaki, KL McClain, ... Cancer 122 (18), 2857-2866, 2016 | 122 | 2016 |
New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy D Chihara, LJ Nastoupil, JN Williams, P Lee, JL Koff, CR Flowers Expert review of anticancer therapy 15 (5), 531-544, 2015 | 120 | 2015 |
Recent advances in the treatment of adult T‐cell leukemia‐lymphomas A Utsunomiya, I Choi, D Chihara, M Seto Cancer science 106 (4), 344-351, 2015 | 116 | 2015 |
Rituximab plus hyper‐CVAD alternating with MTX/Ara‐C in patients with newly diagnosed mantle cell lymphoma: 15‐year follow‐up of a phase II study from the MD Anderson Cancer Center D Chihara, CY Cheah, JR Westin, LE Fayad, MA Rodriguez, ... British journal of haematology 172 (1), 80-88, 2016 | 106 | 2016 |
The survival outcome of patients with relapsed/refractory peripheral T‐cell lymphoma‐not otherwise specified and angioimmunoblastic T‐cell lymphoma D Chihara, MA Fanale, RN Miranda, M Noorani, JR Westin, LJ Nastoupil, ... British journal of haematology 176 (5), 750-758, 2017 | 103 | 2017 |
Long‐term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial D Chihara, H Kantarjian, S O'Brien, J Jorgensen, S Pierce, S Faderl, ... British journal of haematology 174 (5), 760-766, 2016 | 98 | 2016 |
High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma D Chihara, Y Oki, H Onoda, H Taji, K Yamamoto, T Tamaki, Y Morishima International journal of hematology 93, 502-508, 2011 | 94 | 2011 |
Management strategies and outcomes for very elderly patients with diffuse large B‐cell lymphoma D Chihara, JR Westin, Y Oki, MA Ahmed, B Do, LE Fayad, ... Cancer 122 (20), 3145-3151, 2016 | 83 | 2016 |
Randomized phase II study of first-line cladribine with concurrent or delayed rituximab in patients with hairy cell leukemia D Chihara, E Arons, M Stetler-Stevenson, CM Yuan, HW Wang, H Zhou, ... Journal of Clinical Oncology 38 (14), 1527, 2020 | 77 | 2020 |
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy CK Stein-Thoeringer, NY Saini, E Zamir, V Blumenberg, ML Schubert, ... Nature medicine 29 (4), 906-916, 2023 | 63 | 2023 |
Phase 2 study of ibrutinib in classic and variant hairy cell leukemia KA Rogers, LA Andritsos, L Wei, EM McLaughlin, AS Ruppert, ... Blood, The Journal of the American Society of Hematology 137 (25), 3473-3483, 2021 | 56 | 2021 |
Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL) D Chihara, N Asano, K Ohmachi, M Nishikori, M Okamoto, M Sawa, ... Annals of Oncology 26 (5), 966-973, 2015 | 55 | 2015 |
High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B cell lymphoma: a nationwide retrospective study D Chihara, K Izutsu, E Kondo, R Sakai, S Mizuta, K Yokoyama, H Kaneko, ... Biology of Blood and Marrow Transplantation 20 (5), 684-689, 2014 | 55 | 2014 |
Incidence of myelodysplastic syndrome in Japan D Chihara, H Ito, K Katanoda, A Shibata, T Matsuda, T Sobue, K Matsuo Journal of epidemiology 24 (6), 469-473, 2014 | 51 | 2014 |
Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma K Iwama, D Chihara, K Tsuda, T Ugai, H Sugihara, Y Nishida, ... European Journal of Haematology 90 (2), 134-141, 2013 | 50 | 2013 |
Increase in incidence of adult T‐cell leukemia/lymphoma in non‐endemic areas of J apan and the U nited S tates D Chihara, H Ito, K Katanoda, A Shibata, T Matsuda, K Tajima, T Sobue, ... Cancer science 103 (10), 1857-1860, 2012 | 50 | 2012 |